Recruitment for a Study on Type 1 Diabetes & Stigma
Community engagement on exploring stigma specific to people living with type 1 diabetes in diverse ethnic communities

Overview

Egality supported a research study by Imperial College London exploring stigma in people living with type 1 diabetes (T1D), with a focus on reaching individuals from diverse ethnic backgrounds. We partnered with 2 community organisations and 3 people with lived experience to co-develop culturally relevant recruitment materials including videos, posters and pamphlets, to support a targeted online recruitment campaign.

Group discussion with three community advocates living with type 1 diabetes

Outcomes

  • Delivered a 6-month recruitment campaign across social media platforms including Instagram, Facebook, LinkedIn, and X (formerly Twitter), as well as through newsletters and WhatsApp groups
  • Engaged people from South Asian, Black, African, and Caribbean communities living with type 1 diabetes related stigma through community outreach
  • Developed and delivered bespoke materials to increase survey respondents from these underrepresented communities e.g., social media posts, flyers, etc.
  • Developed 10+ videos with 3 community advocates living with type 1 diabetes, including a group discussion on their experiences with stigma, personal anecdotes, etc.

Video outputs

Short videos with community advocates living with type 1 diabetes were developed on issues like:

  • What was your first experience of stigma?
  • How does stigma related to your type 1 diabetes affect your work life?
  • How does stigma related to your type 1 diabetes affect your personal life?
  • What would you say to people who are unaware of the challenges faced by those living with type 1 diabetes?
  • Why do you think its important for people with type 1 diabetes to talk more openly about their stigma and experiences?
Call to action [compiled]

Read more case studies

STEADFAST Study

Recruiting young people with type 1 diabetes

Improving Access to Blood Cancer Trials for Black & Pakistani communities

Developing communications materials to improve engagement in blood cancer clinical trials for Blood Cancer UK and a top-10 pharmaceutical company

Global Patient Councils to Shape a Phase 3 Alzheimer’s Disease Trial

Engaging patients and caregivers from the EU, UK, and US to inform and enhance the patient experience for an upcoming Phase 3 clinical trial on behalf of a global top-10 pharmaceutical company

Take one step to create health equity today